Journal Article Summary
The article investigates the health outcomes of infants born to mothers who were infected with the SARS-CoV-2 virus during pregnancy. This topic is significant as it addresses the potential impacts of COVID-19 on newborns, particularly in a vulnerable population that is publicly insured and often faces socioeconomic challenges. Understanding these outcomes can help healthcare providers better support mothers and infants during and after the pandemic.
The study focused on 33 infants born between April and July 2020 to mothers diagnosed with COVID-19 during pregnancy. Researchers collected data from hospital admissions and follow-up appointments to assess various factors, including breastfeeding rates, growth, and overall health. The findings revealed that most mothers intended to breastfeed, and the infants showed normal growth patterns and high vaccination compliance. However, the rates of breastfeeding at six months were lower than those seen in historical cohorts, indicating a potential area for improvement.
Despite the positive outcomes, the study has limitations, including a small sample size and a focus on a specific health center, which may not represent all populations. Patients and caregivers should be aware of these limitations and discuss any concerns regarding breastfeeding and infant health with their healthcare providers. It is essential to consider individual circumstances and seek personalized advice, especially in the context of ongoing public health challenges.
Medication Safety Note
Pill Pals Pharmacy provides affordable pharmacy solutions for Federally Qualified Health Centers (FQHC)s. Call or email us today to learn more: 855.816.7257 [email protected]
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Schuh Tina L., Mithal Leena B., Naureckas Sara, Miller Emily S., Garfield Craig F., Shah Malika D.. Outcomes from birth to 6 months of publicly insured infants born to mothers with severe acute respiratory syndrome coronavirus 2 infection in the United States. Journal of Perinatal Medicine 2022. DOI: 10.1515/jpm-2021-0251. PMID: 34882359. PMCID: PMC8997689.
Featured Pill Pals Product
Acetaminophen 500 MG Caplets ---1,000 Count --- Generic For Tylenol --- Major / Rugby --- Over The Counter
Acetaminophen 500 MG Caplets —1,000 Count — Generic For Tylenol — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
